|
SFRS6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.645600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.518000E-01 |
| Normal-vs-Stage2 |
9.247400E-01 |
| Normal-vs-Stage3 |
5.878600E-01 |
| Normal-vs-Stage4 |
7.429900E-02 |
| Stage1-vs-Stage2 |
9.825200E-01 |
| Stage1-vs-Stage3 |
6.577600E-01 |
| Stage1-vs-Stage4 |
6.846400E-02 |
| Stage2-vs-Stage3 |
7.609200E-01 |
| Stage2-vs-Stage4 |
2.002000E-01 |
| Stage3-vs-Stage4 |
2.279000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.252800E-01 |
| Normal-vs-AfricanAmerican |
2.605200E-01 |
| Normal-vs-Asian |
2.009400E-01 |
| Caucasian-vs-AfricanAmerican |
4.452300E-02 |
| Caucasian-vs-Asian |
2.349600E-01 |
| AfricanAmerican-vs-Asian |
7.025000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.178300E-02 |
| Normal-vs-Female |
1.542250E-01 |
| Male-vs-Female |
1.776380E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.137000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.980000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.127800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.106000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.327200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.608400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.462400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.913800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.114800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.683200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.317300E-03 |
| Normal-vs-Grade 2 |
2.473200E-01 |
| Normal-vs-Grade 3 |
9.659700E-02 |
| Normal-vs-Grade 4 |
3.837600E-04 |
| Grade 1-vs-Grade 2 |
1.054990E-01 |
| Grade 1-vs-Grade 3 |
2.278800E-03 |
| Grade 1-vs-Grade 4 |
7.58050000000399E-05 |
| Grade 2-vs-Grade 3 |
2.200400E-03 |
| Grade 2-vs-Grade 4 |
1.80740999999873E-05 |
| Grade 3-vs-Grade 4 |
1.210030E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.057400E-01 |
| Normal-vs-ccB subtype |
5.322300E-03 |
| ccA subtype-vs-ccB subtype |
7.85770000000241E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.135800E-01 |
| Normal-vs-N1 |
2.543700E-03 |
| N0-vs-N1 |
3.475700E-02 |
|
|
